Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
复制标题
DOI:
--
复制
发表时间:
1992
期刊:
影响因子:
8
通讯作者:
Ruth Halaban;Jeffrey S. Rubin;Yoko Funasaka;Melanie H. Cobb;Teri G. Boulton;D. Faletto;Eliot M. Rosen;Andrew Chan;Karen Yoko;W. White;Christopher Cook;Gisela Moellmann
中科院分区:
文献类型:
--
作者:
Ruth Halaban;Jeffrey S. Rubin;Yoko Funasaka;Melanie H. Cobb;Teri G. Boulton;D. Faletto;Eliot M. Rosen;Andrew Chan;Karen Yoko;W. White;Christopher Cook;Gisela Moellmann
The proto-oncogene c-MET encodes a transmembrane tyrosine kinase receptor for hepatocyte growth factor/scatter factor (HGF/SF). HGF/SF stimulates the proliferation and motility of various cell types. Because HGF/SF is also a melanocyte mitogen, we investigated the biological role of HGF/SF, including c-Met expression, activation and signal transduction, in normal and malignant human melanocytes. We show that HGF/SF is mitogenic in the presence of synergistic factors, such as basic fibroblast growth factor (bFGF) and mast cell growth factor (MGF) and that, by itself, it stimulates the motility of normal human melanocytes. The ligand also maintained high levels of tyrosinase activity and melanin content in theses cells. Signal transduction by HGF/SF included phosphorylation of tyrosyl residues on c-Met, a cascade of tyrosine phosphorylations on several other proteins and activation of microtubule-associated protein kinase/extracellular signal-regulated kinase. Met expression and activity are normal in human melanomas, and constitutive activity of HGF/SF in retrovirally infected autonomously proliferative mouse melanocytes is insufficient to confer the malignant phenotype. Our findings suggest that activation of Met in response to HGF/SF may contribute to malignant progression synergistically with the aberrant expression of bFGF in malignant melanocytes and that, in addition, the peptide may promote dispersion of factor-dependent melanocytes from early stages of primary melanomas to ectopic sites.